|
|
|
|
Vol. 9, Issue 4, 701-713, April 1998
Washington University School of Medicine, Department of
Biochemistry and Molecular Biophysics, St. Louis, Missouri 63110
bEND.3 cells are polyoma middle T-transformed mouse brain
endothelial cells that express very little or no thrombospondin-1, a
natural inhibitor of angiogenesis, but express high levels of platelet
endothelial cell adhesion molecule-1 (PECAM-1) that localizes to sites
of cell-cell contact. Here, we have examined the role of PECAM-1 in
regulation of bEND.3 cell proliferation, migration, morphogenesis, and
hemangioma formation. We show that down-regulating PECAM-1 expression
by antisense transfection of bEND.3 cells has a dramatic effect on
their morphology, proliferation, and morphogenesis on Matrigel. There
is an optimal level for PECAM-1 expression such that high levels of
PECAM-1 inhibit, whereas moderate levels of PECAM-1 stimulate,
endothelial cell morphogenesis. The down-regulation of PECAM-1 in
bEND.3 cells resulted in reexpression of endogenous thrombospondin-1
and its antiangiogenic receptor CD36. The expression of the vascular
endothelial growth factor receptors flk-1 and flt-1, as well as
integrins and metalloproteinases (which are involved in
angiogenesis), were also affected. These observations are consistent
with the changes observed in proliferation, migration, and adhesion
characteristics of the antisense-transfected bEND.3 cells as well as
with their lack of ability to form hemangiomas in mice. Thus, a
reciprocal relationship exists between thrombospondin-1 and PECAM-1
expression, such that these two molecules appear to be constituents of
a "switch" that regulates in concert many components of the
angiogenic and differentiated phenotypes of endothelial cells.
This article has been cited by other articles:
![]() |
D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model J. Ultrasound Med., June 1, 2008; 27(6): 855 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sezaki, S. Hirohata, A. Iwabu, K. Nakamura, K. Toeda, T. Miyoshi, H. Yamawaki, K. Demircan, S. Kusachi, Y. Shiratori, et al. Thrombospondin-1 Is Induced in Rat Myocardial Infarction and Its Induction Is Accelerated by Ischemia/Reperfusion Experimental Biology and Medicine, October 1, 2005; 230(9): 621 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Keezer, S. E. Ivie, H. C. Krutzsch, A. Tandle, S. K. Libutti, and D. D. Roberts Angiogenesis Inhibitors Target the Endothelial Cell Cytoskeleton through Altered Regulation of Heat Shock Protein 27 and Cofilin Cancer Res., October 1, 2003; 63(19): 6405 - 6412. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, M.-N. Wang, H. Li, K. D. King, R. Bassi, H. Sun, A. Santiago, A. T. Hooper, P. Bohlen, and D. J. Hicklin Active Immunization Against the Vascular Endothelial Growth Factor Receptor flk1 Inhibits Tumor Angiogenesis and Metastasis J. Exp. Med., June 17, 2002; 195(12): 1575 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kragh, B. Quistorff, M. Tenan, E. G. Van Meir, and E. G. Kristjansen Overexpression of Thrombospondin-1 Reduces Growth and Vascular Index but not Perfusion in Glioblastoma Cancer Res., February 1, 2002; 62(4): 1191 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. RayChaudhury, M. Elkins, D. Kozien, and M. T. Nakada Regulation of PECAM-1 in Endothelial Cells during Cell Growth and Migration Experimental Biology and Medicine, July 1, 2001; 226(7): 686 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Robinson and S. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell Sci., January 3, 2001; 114(5): 853 - 865. [Abstract] [PDF] |
||||
![]() |
J. R. Gamble, J. Drew, L. Trezise, A. Underwood, M. Parsons, L. Kasminkas, J. Rudge, G. Yancopoulos, and M. A. Vadas Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions Circ. Res., September 29, 2000; 87(7): 603 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sheibani, C. M. Sorenson, and W. A. Frazier Differential Modulation of Cadherin-mediated Cell-Cell Adhesion by Platelet Endothelial Cell Adhesion Molecule-1 Isoforms through Activation of Extracellular Regulated Kinases Mol. Biol. Cell, August 1, 2000; 11(8): 2793 - 2802. [Abstract] [Full Text] |
||||
![]() |
A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1 Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388. [Abstract] [Full Text] |
||||
![]() |
S. Yang, J. Graham, J. W. Kahn, E. A. Schwartz, and M. E. Gerritsen Functional Roles for PECAM-1 (CD31) and VE-Cadherin (CD144) in Tube Assembly and Lumen Formation in Three-Dimensional Collagen Gels Am. J. Pathol., September 1, 1999; 155(3): 887 - 895. [Abstract] [Full Text] [PDF] |
||||